Details

Autor(en) / Beteiligte

• Liu, Shao-Hsien, MPH
• Dubé, Catherine E., EdD
• Driban, Jeffrey B., PhD
• McAlindon, Timothy E., MD, MPH
• Eaton, Charles B., MD, MS
• Lapane, Kate L., PhD, MS

Titel

Patterns of intra-articular injection use after initiation of treatment in patients with knee osteoarthritis: data from the Osteoarthritis Initiative

Ist Teil von

• Osteoarthritis and cartilage, 2017-10, Vol.25 (10), p.1607-1614

Ort / Verlag

England: Elsevier Ltd

Erscheinungsjahr

2017

Quelle

ScienceDirect

Beschreibungen/Notizen

• Summary Objective We sought to describe and evaluate longitudinal use of intra-articular injections after treatment initiation among adults with radiographically confirmed knee osteoarthritis (OA). Method Using data from the Osteoarthritis Initiative, we included participants with radiographically confirmed OA (Kellgren-Lawrence grade (K-L) ≥ 2) in ≥ 1 knee at baseline. With 9 years of data, 412 participants newly initiating hyaluronic acid or corticosteroid injections with their index visit were identified. For each type of injection initiated, socio-demographic and clinical characteristics were described by patterns of treatments (one-time use, switched, or continued injections). Multinomial logistic models estimated the extent to which patient-reported symptoms (post-initial injection and changes over time) were associated with patterns of injection use. Results Of those initiating injections, ∼19% switched, ∼21% continued injection type, and ∼60% did not report any additional injections. For participants initiating corticosteroid injections, greater symptoms post-initial injection were associated with lower odds of continued use compared to one-time users (adjusted odds ratio (aOR) for WOMAC pain: 0.91; 95%, confidence interval (CI): 0.83 to 0.99; aORstiffness : 0.77; CI: 0.63 to 0.94; aORphysical function : 0.97; CI: 0.94 to 1.00). Symptom changes over time (e.g. worsened or improved) were not associated with patterns of injections use. Conclusion After treatment initiation, the proportion of patients switching injection use and one-time users was substantial. Symptoms post-initial injection appear to be associated with patterns of injection use. The extent to which these patterns are an indication of lack of impact on patient-reported symptoms should be explored.